Hypokalemia and Hypertension Associated with Supratherapeutic Posaconazole Levels.
Division of Infectious Disease, Mayo Clinic, Rochester, Minnesota, USA mahmood.maryam@mayo.edu.
Maryam
M
Mahmood
Division of Infectious Disease, Mayo Clinic, Rochester, Minnesota, USA.
Omar
O
Abu Saleh
Division of Infectious Disease, Mayo Clinic, Rochester, Minnesota, USA.
M Rizwan
MR
Sohail
D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects* / Q000097:blood; D006660:Histoplasmosis / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D007008:Hypokalemia / Q000139:chemically induced*; D016403:Lymphoma, Large B-Cell, Diffuse; D008297:Male; D009181:Mycoses / Q000517:prevention & control; D014230:Triazoles / Q000009:adverse effects* / Q000097:blood
D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole
fungal infections; infectious disease